Term
|
Definition
|
|
Term
|
Definition
- Bronchospasm due to bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders.
- Respiratory distress with bronchospasm.
|
|
|
Term
|
Definition
- Hypersensitivity to salbutamol.
|
|
|
Term
|
Definition
- Should not be used with patients presenting with acute heart failure.
- Cardiovascular diseases such as cardiac dysrhythmias and hypertension.
- Patents with diabetes mellitus can risk further reducing serum potassium levels and lead to possible adverse cardiovascular events.
|
|
|
Term
|
Definition
- Nervousness
- Nausea/Vomiting
- Headache
- Heart palpitations
- Tachycardia
- Transient muscle cramps
- Muscle tremors
- Weakness
|
|
|
Term
|
Definition
- Nebulizer = 2.5mg – 5.0mg nebule, repeat every 5 minutes as needed.
- MDI = min 6 puffs, max 20 puffs, each puff is 100mcg.
|
|
|
Term
|
Definition
- Nebulizer = 0.15mg per kg diluted to 2.5ml in NS OR
- Patients less than 10kg: 1.25mg diluted in NS to 2.5ml.
- Patients 10kg to 20kg: 2.5mg
- Patients greater than 20kg: 2.5mg to 5.0mg
- MDI = 2 puffs, max 10, each puff is 100mcg.
|
|
|
Term
|
Definition
- Use of EMS service medication is preferred over using patient’s medication.
- Nebulized is the preferred method of delivery.
|
|
|
Term
|
Definition
- Bronchodilator: Beta 2 selective adrenergic agonist (sympathomimetic).
|
|
|
Term
|
Definition
- Selectively stimulates the beta-adrenergic receptors of the lungs, uterus and vascular smooth muscles.
- Bronchodilation results from the relaxation of the vascular smooth muscles, which relieves bronchospasm and reduces airway resistance.
- Higher doses will drive serum potassium into the cells.
|
|
|
